Literature DB >> 18805348

Etiology and clinical characteristics of membranous nephropathy in Chinese patients.

Cai-Hong Zeng1, Hui-mei Chen, Rui-Shi Wang, Yan Chen, Su-Hua Zhang, Li Liu, Lei-Shi Li, Zhi-Hong Liu.   

Abstract

BACKGROUND: Membranous nephropathy (MN) is a common cause of proteinuria and can be subdivided into idiopathic and secondary classifications. Most patients with MN present with associated systemic diseases that need to be identified before appropriately diagnosing idiopathic MN. However, the cause and clinical characteristics of MN in Chinese patients have not been investigated. STUDY
DESIGN: Case series. SETTING & PARTICIPANTS: Patients with biopsy-proven MN at the Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. OUTCOME: The diagnosis of idiopathic and secondary MN was based on clinical, initial laboratory, and histological findings.
RESULTS: 390 patients with MN were identified from 1985 to 2005. Of 390 patients with MN, 124 (31.8%) had idiopathic MN and 266 had secondary MN (68.2%). Of patients with idiopathic MN, 75 (60.5%) were men and 49 (39.5%) were women. Mean age was 43.9 +/- 13.2 years (range, 14 to 78 years). Common presentations of idiopathic MN were 60.5% with proteinuria (39.5% of whom presented with nephrotic syndrome), 29.8% with hypertension, 17.7% with hematuria, and 0.8% with decreased kidney function. In patients with secondary MN, causes were autoimmune diseases (73.3%), infections (17.7%), tumors (4.5%), and drugs or toxins (4.5%). Systemic lupus erythematosus was the most common autoimmune disease (predominately in younger women). Hepatitis B predominated in younger men. Greater levels of proteinuria were found in patients who presented with drugs or toxins compared with patients with other secondary MNs (P < 0.05). LIMITATIONS: Not all patients underwent all tests, particularly serum tumor markers, hepatitis C virus antibody, and hepatitis C virus RNA tests.
CONCLUSION: Proteinuria was a common presentation in patients with idiopathic MN, which was predominately found in middle-aged to elderly men. Secondary MN was more common than idiopathic MN, and most secondary MN diagnoses were secondary to systemic lupus erythematosus and hepatitis B infection.

Entities:  

Mesh:

Year:  2008        PMID: 18805348     DOI: 10.1053/j.ajkd.2008.06.006

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  23 in total

1.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

2.  Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy.

Authors:  Wenling Ye; Yingyi Wang; Yubing Wen; Hang Li; Xuemei Li
Journal:  Int Urol Nephrol       Date:  2014-01-11       Impact factor: 2.370

3.  Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.

Authors:  Xu Yu-Zhu; Huang Na-Ya; Qiu Ya-Gui; Chen Xiong-Hui; Li Zhi-Jian; Chen Wei; Wang Xin
Journal:  Clin Exp Med       Date:  2021-10-26       Impact factor: 5.057

4.  Mercury-induced membranous nephropathy: clinical and pathological features.

Authors:  Shi-Jun Li; Su-Hua Zhang; Hui-Ping Chen; Cai-Hong Zeng; Chun-Xia Zheng; Lei-Shi Li; Zhi-Hong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

5.  Hepatitis B and Renal Disease.

Authors:  Tak Mao Chan
Journal:  Curr Hepat Rep       Date:  2010-04-14

6.  Lupus-like membranous nephropathy: Is it lupus or not?

Authors:  Ramin Sam; Amit Joshi; Sam James; Kuang-Yu Jen; Firouz Amani; Peter Hart; Melvin M Schwartz
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

Review 7.  Rituximab therapy in nephrotic syndrome: implications for patients' management.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

8.  Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.

Authors:  Jicheng Lv; Wanyin Hou; Xujie Zhou; Gang Liu; Fude Zhou; Na Zhao; Ping Hou; Minghui Zhao; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

Review 9.  Membranous nephropathy: not just a disease for adults.

Authors:  Rivka Ayalon; Laurence H Beck
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

10.  Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.

Authors:  In O Sun; Yu Ah Hong; Hoon Suk Park; Sun Ryoung Choi; Byung Ha Chung; Cheol Whee Park; Chul Woo Yang; Yong Soo Kim; Bum Soon Choi
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.